Industry Symposia 2025 – 4th of September
No CPD credits
IUCS is a sponsored event. All companies sponsoring the event are named and have no input into the content of the programme or the selection of speakers, except in the case of dedicated sponsored symposium sessions, which are clearly identified in the conference programme. IUCS receives exhibition sponsorship from pharmaceutical companies and other trade partners.
14.10 – 14.30
ADT in prostate cancer – Getting to the heart of the matter
Prof Amit Bahl, Consultant Clinical Oncologist, University Hospitals Bristol NHS Trust, UK
14:30 – 14:50
The PRopel study: Advancing Patient-Centered Care in mCRPC
Dr Will Ince, Consultant oncologist, Addenbrookes Hospital, Cambridge University Hospitals NHS Trust, UK
Dr Carla Perna, consultant oncologist, Royal Surrey County Hospital and Frimley Health NHS Trust, UK
Andrew Hunnisett, Trainee Advanced specialist practitioner in uro oncology, Royal Blackburn Hospital, UK
5th September
10:10 – 10:30
This promotional symposium is organised and fully funded by Eisai
Navigating treatment strategies for first-line advanced Renal Cell Carcinoma
Prof. Dr. Viktor Grünwald,University Hospital Essen, Germany
Dr. Will Ince, Consultant Oncologist, Addenbrooke’s Hospital – Affiliated Assistant Professor, University of Cambridge, UK
10:30 – 10:50
Expert Debate: Combination Versus Monotherapy Strategies in Favourable Risk mRCC
Faculty
Chair: Prof. Laurence Albiges, Head of Department of Oncology, Institut Gustave Roussy, Villejuif, France
Dr. Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre, Cardiff, UK
Dr. Will Ince, Clinical Associate Professor and Consultant Clinical Oncologist, Addenbrooke’s Hospital, Cambridge, UK